2026-04-26T09:23:36Z
https://www.pub.unibl.org/oai
oai:pub.unibl.org:64457
2026-01-06T04:43:32Z
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
https://www.unibl.org/sr-lat/fis/zaposlen/3403-ljubinka-bozic
2016-09
Academic Article
text
/unibl/sci/idNaucniRad:36016
https://dx.doi.org//unibl/sci/idNaucniRad:24619
STED Journal
2637-2150
STED Journal
2637-2150
LJ. Božić, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, Sep, 2016